2024-11-13T15:59:47-05:00 2023-12-31 731681968 BLAIR C DIAZ CPA PC 616 GREEN ST GAINESVILLE GA 30501 990 2023-01-01 863948612 KNOX MARTIN FOUNDATION FOR BRAIN CANCER RESEARCH KNOX 7705363381 700 LINDSEY BAKER COURT GAINESVILLE GA 30506 REBECKA DENISE MARTIN PRESIDENT/CEO 7705363381 2024-11-08 false BLAIR C DIAZ P00632595 7705365500 2024-11-08 2023 2024-10-15 13:58:12Z REBECKA DENISE MARTIN 700 LINDSEY BAKER COURT GAINESVILLE GA 30506 631769 false X WWW.KNOXMARTINFOUNDATION.ORG X 2021 GA THE KNOX MARTIN FOUNDATION FOR BRAIN CANCER RESEARCH WAS CREATED TO FUND THE NEXT BREAKTHROUGH IN BRAIN CANCER - PARTICULARLY IN AGGRESSIVE BRAIN CANCERS - GIVING WARRIORS LIKE KNOX MARTIN A LONGER LIFE EXPECTANCY. 12 10 2 20 0 546174 449792 0 109 1047 -40849 37427 505434 488266 300000 250000 0 50896 142447 0 47231 37289 72427 388185 464874 117249 23392 148429 178842 949 148429 177893 TO REVERSE THE UNDERFUNDED AND UNDER-RESEARCHED NATURE OF BRAIN CANCER BY FUNDING INNOVATIVE RESEARCH ON THE MOST AGGRESSIVE FORMS OF BRAIN CANCER - GLIOBLASTOMA (GBM). false false 365090 250000 TO IDENTIFY AND FUND LABS AND/OR RESEARCHERS WHO ARE CONDUCTING THE MOST INNOVATIVE AND PROMISING RESEARCH FOR BRAIN TUMOR/BRAIN CANCER TREATMENT. OUR VISION IS A WORLD WHERE A GBM DIAGNOSIS IS TREATABLE AND CURABLE. 365090 true true false false false false false false false false false false false false false false false false false false false false false false true false false true false false false false false false false false false false false false false false false false false false false true 2 0 2 false false false false false false true true false false false false false false X 12 10 false false false false false false false true true false false true true true true true false true false false GA X JOSEPH PAUL STARK 7705363381 700 LINDSEY BAKER COURT GAINESVILLE GA 30506 REBECKA DENISE MARTIN PRESIDENT/CE 40.00 X X 90000 0 0 MADISON ELIZABETH LETTS COO 40.00 X X 39268 0 0 PATRICK BROOKS BAUGHMAN BOARD CHAIR 5.00 X X 0 0 0 WADE STEDMAN COX BOARD VICE C 5.00 X X 0 0 0 GABRIEL JOHN FINGER DIRECTOR OF 2.00 X 0 0 0 LUCAS J JENKINS DIR OF BUSIN 1.00 X 0 0 0 WILLIAM COLE LACKEY DIR OF HOSPI 3.00 X 0 0 0 WILLIAM RILEY MARTIN HISTORIAN 0.50 X 0 0 0 SAMUEL RICHARD NEVERS DIRECTOR OF 1.00 X 0 0 0 JOSEPH PAUL STARK CFO 3.00 X X 0 0 0 LAUREN CHANDLER WATTS DIRECTOR OF 1.00 X 0 0 0 129268 false false false 17500 432292 449792 1047 1047 179040 17500 143503 35537 REWARDS INCOME 1890 1890 1890 488266 2937 250000 250000 129268 77561 19390 32317 13179 7907 1977 3295 7634 7634 4784 1196 3588 10996 554 10116 326 3010 1024 993 993 32303 19382 8076 4845 12714 7466 3381 1867 267 267 719 719 464874 365090 52553 47231 147169 157446 14000 1260 7396 148429 178842 949 0 949 X 148429 177893 148429 177893 148429 178842 23392 6072 X true X false false X 146580 546174 449792 1142546 146580 546174 449792 1142546 283085 859461 1047 1047 890 890 1144483 264316 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED NIGHT FOR KNOX 196540 17500 179040 8169 70395 2742 62197 196540 17500 179040 8169 70395 2742 62197 143503 35537 false DUKE CANCER INSTITUTE PRESTON ROBERT TISCH BRAIN TUMOR CT 300 W MORGAN STREET SUITE 1200 DURHAM NC 27710 560532129 501C3 250000 RESEARCH GRANT 1 SCHEDULE I, PAGE 1, PART I, LINE 2 APPROXIMATELY HALF OF THE BOARD'S TIME IS SPENT RESEARCHING, IDENTIFYING, AND ALLOCATING FUNDS TO A LAB AND/OR RESEARCHER(S) WHOM WE BELIEVE IS/ARE CURRENTLY CONDUCTING THE MOST INNOVATIVE AND PROMISING RESEARCH FOR BRAIN TUMOR/BRAIN CANCER TREATMENT. INITIALLY, WE SELECTED GRANT RECIPIENTS BASED ON OUR OWN RESEARCH AND INQUIRIES OF NEED. BEGINNING IN 2022, GRANT RECIPIENTS WILL COMPLETE AN ONLINE APPLICATION OUTLINING THEIR NEED FOR FUNDING AND HOW IT RELATES TO OUR MISSION STATEMENT. WE WILL REQUIRE THEM TO MAINTAIN AND PROVIDE AN ACCOUNTING OF ALL FUNDS USED. WE WILL INVESTIGATE THEIR STATUS WITH A THIRD PARTY SUCH AS BETTER BUSINESS BUREAU. WE BELIEVE THESE PRE-RESEARCH GRANT DISTRIBUTION GUARDRAILS PROVIDE ASSURANCE THAT THE FUNDS WILL BE USED ACCORDING TO THE RECIPIENT'S GRANT REQUEST. FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED IN DETAIL BY THE PRESIDENT AND TREASURER WITH THE CPA. IT IS THEN SENT TO THE ENTIRE BOARD BEFORE IT IS FILED. FORM 990, PAGE 6, PART VI, LINE 12C UPON RECEIVING A DISCLOSURE, THE FOUNDATION'S CEO AND CHAIRMAN OF THE BOARD OF DIRECTORS SHALL REVIEW THE CONFLICT AND MAKE A RECOMMENDATION TO THE BOARD OF DIRECTORS REGARDING THE APPROPRIATE COURSE OF ACTION. DEPENDING ON THE CIRCUMSTANCES, THE BOARD MAY: A. REQUEST ADDITIONAL INFORMATION FROM THE INDIVIDUAL INVOLVED. B. DECIDE THAT THE CONFLICT DOES NOT REQUIRE FURTHER ACTION. C. REQUIRE THE INDIVIDUAL TO RECUSE THEMSELVES FROM ANY DECISION-MAKING PROCESSES OR ACTIVITIES RELATED TO THE CONFLICT. D. ESTABLISH SAFEGUARDS TO MITIGATE THE CONFLICT, SUCH AS SUPERVISORY OVERSIGHT, RESTRICTIONS ON INVOLVEMENT, OR OTHER MEASURES. E. TAKE ANY OTHER ACTION DEEMED NECESSARY TO PROTECT THE FOUNDATION'S INTERESTS. ALL CONFLICTS OF INTEREST, DISCLOSURES, AND ACTIONS TAKEN TO ADDRESS THEM SHALL BE DOCUMENTED IN THE FOUNDATION'S RECORDS. THIS DOCUMENTATION SHALL INCLUDE THE NATURE OF THE CONFLICT, THE NAMES OF INDIVIDUALS INVOLVED, THE BOARD'S DECISIONS, AND ANY ACTIONS TAKEN TO MANAGE OR MITIGATE THE CONFLICT. ALL DIRECTORS, OFFICERS, AND EMPLOYEES SHALL ANNUALLY AFFIRM THEIR UNDERSTANDING OF THIS POLICY AND DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST THAT MAY HAVE ARISEN DURING THE YEAR. VIOLATION OF THIS CONFLICT OF INTEREST POLICY MAY RESULT IN DISCIPLINARY ACTION, UP TO AND INCLUDING TERMINATION OF EMPLOYMENT OR REMOVAL FROM THE BOARD, DEPENDING ON THE SEVERITY AND CIRCUMSTANCES OF THE VIOLATION. FORM 990, PAGE 6, PART VI, LINE 15A THE BOARD APPROVES THE COMPENSATION OF THE PRESIDENT/CEO USING COMPARABILITY DATA. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.